Verano Holdings (VRNO) Assets Average (2022 - 2026)
Verano Holdings' (VRNO) quarterly Assets Average came in at $1.7 billion in Q1 2026, down 12.95% year-on-year from $2.0 billion in Q1 2025, and down 5.92% on a QoQ basis from $1.8 billion in Q4 2025.
Verano Holdings (VRNO) Assets Average (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 5 years of Assets Average data on file, last reported at $1.7 billion in Q1 2026.
- On a quarterly basis, Assets Average fell 12.95% year-over-year to $1.7 billion in Q1 2026; TTM through Mar 2026 was $1.7 billion, a 12.95% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, down 13.38% from the prior year.
- Assets Average for Q1 2026 stood at $1.7 billion, down from $1.8 billion in the prior quarter.
- Over the last five years, Assets Average for VRNO reached as high as $2.6 billion in Q3 2022 and fell as low as $1.7 billion in Q1 2026.
- Historically, Assets Average has averaged $2.2 billion across 5 years, with a median of $2.3 billion in 2024.
- Across the five-year window, Assets Average slipped 2.75% in 2024 and retreated 15.08% in 2025, its largest moves.
- Year by year, Assets Average stood at $2.5 billion in 2022, then fell by 6.88% to $2.3 billion in 2023, then slipped by 7.81% to $2.2 billion in 2024, then fell by 14.9% to $1.8 billion in 2025, then slipped by 5.92% to $1.7 billion in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $1.7 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 1.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 Bn |
| Dec 31, 2025 | 1.83 Bn |
| Sep 30, 2025 | 1.93 Bn |
| Jun 30, 2025 | 1.96 Bn |
| Mar 31, 2025 | 1.98 Bn |
| Dec 31, 2024 | 2.15 Bn |
| Sep 30, 2024 | 2.28 Bn |
| Jun 30, 2024 | 2.28 Bn |
| Mar 31, 2024 | 2.32 Bn |
| Dec 31, 2023 | 2.34 Bn |
| Sep 30, 2023 | 2.35 Bn |
| Jun 30, 2023 | 2.36 Bn |
| Mar 31, 2023 | 2.38 Bn |
| Dec 31, 2022 | 2.51 Bn |
| Sep 30, 2022 | 2.61 Bn |